FREE CASE EVALUATION: 1-800-632-1404
A recent Xarelto lawsuit initiated by a Madison woman has sought over $4.35 million in damages and recovery of other costs. Filed in the St. Clair County Circuit Court, it claims that the plaintiff suffered from internal bleeding as the blood thinner “failed to congeal in a timely manner.” Janssen and Bayer Healthcare spent over $10 million to promote Xarelto as a superior alternative to Warfarin, which is contested by many recent studies. The drug earned about $600 million in sales in 2012.
Our firm has filed a lawsuit involving Xarelto and welcomes the opportunity to discuss a new claim with you.
Bernadette Fuller took the drug, like many other victims, to subdue deep vein thrombosis and prevent strokes. However, she became ill after ingesting the drug and had severe internal bleeding that was irreversible in the absence of any Xarelto blood thinner antidote. Her Xarelto attorney accused the manufacturers of hyping the positive research findings without highlighting “the increased risk of gastrointestinal bleeding and bleeding that required transfusion among other serious bleeding concerns.”
Xarelto bleeding side effects result in people with greater chance of hemorrhage risk, according to three studies – “the Einstein studies, the Record studies, the Rocket AF study” – carried out during the clinical trial phase. However, Bayer and Janssen deliberately suppressed the adverse anti-coagulation effects while running promotional campaigns exaggerating the drug effectiveness, which led to injuries and deaths.
The Xarelto blood thinner lawsuit evokes “product liability, intentional infliction of emotional distress, negligent infliction of emotional distress, common law fraud, negligence, negligent misrepresentation, fraudulent misrepresentation and strict products liability” to sue the manufacturers citing personal injuries, medical costs, wage loss, and diminished life following illness.
Xarelto Complaints Outnumber Pradaxa
Xarelto have overtaken Pradaxa both in sales and complaints. The blood thinner accounted for at least 2,081 serious injuries and 151 deaths in 2012. According to the Institute for Safe Medication Practices, the drug was among the “10 most frequently named” medications with adverse events.
In 2014, Xarelto exceeded Pradaxa in number of prescriptions and consequently, the number of complaints eclipsed Pradaxa. A May 2014 ISMP report indicated at least 200 patients died and 680 suffered grievous injuries in the first four months of 2013 following Xarelto bleeding side effects. The figures may go up many times to thousands, as only one-tenth of adverse events were reported to the FDA. The report also warned that Xarelto adverse events were “steadily increasing” with a rise in the use by consumers.
Over 4,000 Pradaxa lawsuits filed against its maker Boehringer Ingelheim were settled in May 2014 for $650 million. In December 2014, the USMDL ordered pre-trial centralization of two dozens of Xarelto lawsuits filed in 10 different states in the court of Judge Eldon E. Fallon of Louisiana Eastern District.
Study Rejects Stated Xarelto Advantage Over Warfarin
A Canadian study has claimed that new generation blood thinner Xarelto is “no safer” that Warfarin oral anti-coagulant, which has been prescribed for over six decades. Published in the Canadian Journal of Cardiology last month, the report was based on an analysis of safety profiles of Pradaxa, Warfarin, and Xarelto blood thinners at Ontario-based Southlake Regional Health Centre.
Researchers found identical safety profiles and side effects of blood thinners while exploring over 900 case studies of users. They found “no significant difference” in bleeding events and action off drugs during the treatment of atrial fibrillation. It blunts the manufacturer claim that Xarelto, which is expensive and with potential more side effects, has an edge over Warfarin.
Xarelto lawsuits filed claim that the drug leads to “uncontrollable bleeding among users” and it become life-threatening in the absence of reversal antidote.
If you have a potential claim related to the blood thinner side effects, please contact us or call on 1-800-632-1404 for a free consultation with our experienced Xarelto attorney.
Contact a Xarelto Injury Lawyer Today.
If you or a loved one was injured or died after ingesting Xarelto, please contact us immediately.
For a Free Case Evaluation:
TOLL FREE: 1-800-632-1404
EMAIL: click here
FILL OUT THIS FORM:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.
One Reply to “Xarelto Lawsuit Numbers Climb, Outnumber Pradaxa”